Click for best price
Phase I IV Clinical Development Services Market Size, Share 2022
This report contains market size and forecasts of Phase I - IV Clinical Development Services in Global, including the following market information:
Global Phase I - IV Clinical Development Services Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Phase I - IV Clinical Development Services market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Early Phase Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Phase I - IV Clinical Development Services include Syneos Health, PPD, GVI CDS, Parexel, Clinical Leader, Thermo Fisher Scientific, LabCorp, Worldwide Clinical Trial and CROS NT, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Phase I - IV Clinical Development Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Phase I - IV Clinical Development Services Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Phase I - IV Clinical Development Services Market Segment Percentages, by Type, 2021 (%)
Early Phase
Phase II-III
Phase IIIb-IV
Global Phase I - IV Clinical Development Services Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Phase I - IV Clinical Development Services Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical Companies
Medical Device Companies
Contract Research Organizations
Global Phase I - IV Clinical Development Services Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Phase I - IV Clinical Development Services Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Phase I - IV Clinical Development Services revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Phase I - IV Clinical Development Services revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Syneos Health
PPD
GVI CDS
Parexel
Clinical Leader
Thermo Fisher Scientific
LabCorp
Worldwide Clinical Trial
CROS NT
Dynakin
Rho, Inc.
Synteract
ICBio CRO
Sofpromed
Profil
ICON Plc
Clinipace
OCT Clinical
EPS Group
Beijing Sun-novo Pharmaceutical Research
Dmedglobal
WuXi AppTec
Elixir Clinical Research
| Report Attributes |
Report Details |
| Report Title |
Phase I - IV Clinical Development Services Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
110 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Phase I - IV Clinical Development Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Phase I - IV Clinical Development Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Phase I - IV Clinical Development Services Overall Market Size
2.1 Global Phase I - IV Clinical Development Services Market Size: 2021 VS 2028
2.2 Global Phase I - IV Clinical Development Services Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Phase I - IV Clinical Development Services Players in Global Market
3.2 Top Global Phase I - IV Clinical Development Services Companies Ranked by Revenue
3.3 Global Phase I - IV Clinical Development Services Revenue by Companies
3.4 Top 3 and Top 5 Phase I - IV Clinical Development Services Companies in Global Market, by Revenue in 2021
3.5 Global Companies Phase I - IV Clinical Development Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Phase I - IV Clinical Development Services Players in Global Market
3.6.1 List of Global Tier 1 Phase I - IV Clinical Development Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Phase I - IV Clinical Development Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Phase I - IV Clinical Development Services Market Size Markets, 2021 & 2028
4.1.2 Early Phase
4.1.3 Phase II-III
4.1.4 Phase IIIb-IV
4.2 By Type - Global Phase I - IV Clinical Development Services Revenue & Forecasts
4.2.1 By Type - Global Phase I - IV Clinical Development Services Revenue, 2017-2022
4.2.2 By Type - Global Phase I - IV Clinical Development Services Revenue, 2023-2028
4.2.3 By Type - Global Phase I - IV Clinical Development Services Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Phase I - IV Clinical Development Services Market Size, 2021 & 2028
5.1.2 Pharmaceutical Companies
5.1.3 Medical Device Companies
5.1.4 Contract Research Organizations
5.2 By Application - Global Phase I - IV Clinical Development Services Revenue & Forecasts
5.2.1 By Application - Global Phase I - IV Clinical Development Services Revenue, 2017-2022
5.2.2 By Application - Global Phase I - IV Clinical Development Services Revenue, 2023-2028
5.2.3 By Application - Global Phase I - IV Clinical Development Services Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Phase I - IV Clinical Development Services Market Size, 2021 & 2028
6.2 By Region - Global Phase I - IV Clinical Development Services Revenue & Forecasts
6.2.1 By Region - Global Phase I - IV Clinical Development Services Revenue, 2017-2022
6.2.2 By Region - Global Phase I - IV Clinical Development Services Revenue, 2023-2028
6.2.3 By Region - Global Phase I - IV Clinical Development Services Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Phase I - IV Clinical Development Services Revenue, 2017-2028
6.3.2 US Phase I - IV Clinical Development Services Market Size, 2017-2028
6.3.3 Canada Phase I - IV Clinical Development Services Market Size, 2017-2028
6.3.4 Mexico Phase I - IV Clinical Development Services Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Phase I - IV Clinical Development Services Revenue, 2017-2028
6.4.2 Germany Phase I - IV Clinical Development Services Market Size, 2017-2028
6.4.3 France Phase I - IV Clinical Development Services Market Size, 2017-2028
6.4.4 U.K. Phase I - IV Clinical Development Services Market Size, 2017-2028
6.4.5 Italy Phase I - IV Clinical Development Services Market Size, 2017-2028
6.4.6 Russia Phase I - IV Clinical Development Services Market Size, 2017-2028
6.4.7 Nordic Countries Phase I - IV Clinical Development Services Market Size, 2017-2028
6.4.8 Benelux Phase I - IV Clinical Development Services Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Phase I - IV Clinical Development Services Revenue, 2017-2028
6.5.2 China Phase I - IV Clinical Development Services Market Size, 2017-2028
6.5.3 Japan Phase I - IV Clinical Development Services Market Size, 2017-2028
6.5.4 South Korea Phase I - IV Clinical Development Services Market Size, 2017-2028
6.5.5 Southeast Asia Phase I - IV Clinical Development Services Market Size, 2017-2028
6.5.6 India Phase I - IV Clinical Development Services Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Phase I - IV Clinical Development Services Revenue, 2017-2028
6.6.2 Brazil Phase I - IV Clinical Development Services Market Size, 2017-2028
6.6.3 Argentina Phase I - IV Clinical Development Services Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Phase I - IV Clinical Development Services Revenue, 2017-2028
6.7.2 Turkey Phase I - IV Clinical Development Services Market Size, 2017-2028
6.7.3 Israel Phase I - IV Clinical Development Services Market Size, 2017-2028
6.7.4 Saudi Arabia Phase I - IV Clinical Development Services Market Size, 2017-2028
6.7.5 UAE Phase I - IV Clinical Development Services Market Size, 2017-2028
7 Players Profiles
7.1 Syneos Health
7.1.1 Syneos Health Corporate Summary
7.1.2 Syneos Health Business Overview
7.1.3 Syneos Health Phase I - IV Clinical Development Services Major Product Offerings
7.1.4 Syneos Health Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.1.5 Syneos Health Key News
7.2 PPD
7.2.1 PPD Corporate Summary
7.2.2 PPD Business Overview
7.2.3 PPD Phase I - IV Clinical Development Services Major Product Offerings
7.2.4 PPD Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.2.5 PPD Key News
7.3 GVI CDS
7.3.1 GVI CDS Corporate Summary
7.3.2 GVI CDS Business Overview
7.3.3 GVI CDS Phase I - IV Clinical Development Services Major Product Offerings
7.3.4 GVI CDS Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.3.5 GVI CDS Key News
7.4 Parexel
7.4.1 Parexel Corporate Summary
7.4.2 Parexel Business Overview
7.4.3 Parexel Phase I - IV Clinical Development Services Major Product Offerings
7.4.4 Parexel Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.4.5 Parexel Key News
7.5 Clinical Leader
7.5.1 Clinical Leader Corporate Summary
7.5.2 Clinical Leader Business Overview
7.5.3 Clinical Leader Phase I - IV Clinical Development Services Major Product Offerings
7.5.4 Clinical Leader Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.5.5 Clinical Leader Key News
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Corporate Summary
7.6.2 Thermo Fisher Scientific Business Overview
7.6.3 Thermo Fisher Scientific Phase I - IV Clinical Development Services Major Product Offerings
7.6.4 Thermo Fisher Scientific Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.6.5 Thermo Fisher Scientific Key News
7.7 LabCorp
7.7.1 LabCorp Corporate Summary
7.7.2 LabCorp Business Overview
7.7.3 LabCorp Phase I - IV Clinical Development Services Major Product Offerings
7.7.4 LabCorp Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.7.5 LabCorp Key News
7.8 Worldwide Clinical Trial
7.8.1 Worldwide Clinical Trial Corporate Summary
7.8.2 Worldwide Clinical Trial Business Overview
7.8.3 Worldwide Clinical Trial Phase I - IV Clinical Development Services Major Product Offerings
7.8.4 Worldwide Clinical Trial Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.8.5 Worldwide Clinical Trial Key News
7.9 CROS NT
7.9.1 CROS NT Corporate Summary
7.9.2 CROS NT Business Overview
7.9.3 CROS NT Phase I - IV Clinical Development Services Major Product Offerings
7.9.4 CROS NT Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.9.5 CROS NT Key News
7.10 Dynakin
7.10.1 Dynakin Corporate Summary
7.10.2 Dynakin Business Overview
7.10.3 Dynakin Phase I - IV Clinical Development Services Major Product Offerings
7.10.4 Dynakin Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.10.5 Dynakin Key News
7.11 Rho, Inc.
7.11.1 Rho, Inc. Corporate Summary
7.11.2 Rho, Inc. Business Overview
7.11.3 Rho, Inc. Phase I - IV Clinical Development Services Major Product Offerings
7.11.4 Rho, Inc. Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.11.5 Rho, Inc. Key News
7.12 Synteract
7.12.1 Synteract Corporate Summary
7.12.2 Synteract Business Overview
7.12.3 Synteract Phase I - IV Clinical Development Services Major Product Offerings
7.12.4 Synteract Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.12.5 Synteract Key News
7.13 ICBio CRO
7.13.1 ICBio CRO Corporate Summary
7.13.2 ICBio CRO Business Overview
7.13.3 ICBio CRO Phase I - IV Clinical Development Services Major Product Offerings
7.13.4 ICBio CRO Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.13.5 ICBio CRO Key News
7.14 Sofpromed
7.14.1 Sofpromed Corporate Summary
7.14.2 Sofpromed Business Overview
7.14.3 Sofpromed Phase I - IV Clinical Development Services Major Product Offerings
7.14.4 Sofpromed Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.14.5 Sofpromed Key News
7.15 Profil
7.15.1 Profil Corporate Summary
7.15.2 Profil Business Overview
7.15.3 Profil Phase I - IV Clinical Development Services Major Product Offerings
7.15.4 Profil Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.15.5 Profil Key News
7.16 ICON Plc
7.16.1 ICON Plc Corporate Summary
7.16.2 ICON Plc Business Overview
7.16.3 ICON Plc Phase I - IV Clinical Development Services Major Product Offerings
7.16.4 ICON Plc Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.16.5 ICON Plc Key News
7.17 Clinipace
7.17.1 Clinipace Corporate Summary
7.17.2 Clinipace Business Overview
7.17.3 Clinipace Phase I - IV Clinical Development Services Major Product Offerings
7.17.4 Clinipace Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.17.5 Clinipace Key News
7.18 OCT Clinical
7.18.1 OCT Clinical Corporate Summary
7.18.2 OCT Clinical Business Overview
7.18.3 OCT Clinical Phase I - IV Clinical Development Services Major Product Offerings
7.18.4 OCT Clinical Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.18.5 OCT Clinical Key News
7.19 EPS Group
7.19.1 EPS Group Corporate Summary
7.19.2 EPS Group Business Overview
7.19.3 EPS Group Phase I - IV Clinical Development Services Major Product Offerings
7.19.4 EPS Group Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.19.5 EPS Group Key News
7.20 Beijing Sun-novo Pharmaceutical Research
7.20.1 Beijing Sun-novo Pharmaceutical Research Corporate Summary
7.20.2 Beijing Sun-novo Pharmaceutical Research Business Overview
7.20.3 Beijing Sun-novo Pharmaceutical Research Phase I - IV Clinical Development Services Major Product Offerings
7.20.4 Beijing Sun-novo Pharmaceutical Research Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.20.5 Beijing Sun-novo Pharmaceutical Research Key News
7.21 Dmedglobal
7.21.1 Dmedglobal Corporate Summary
7.21.2 Dmedglobal Business Overview
7.21.3 Dmedglobal Phase I - IV Clinical Development Services Major Product Offerings
7.21.4 Dmedglobal Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.21.5 Dmedglobal Key News
7.22 WuXi AppTec
7.22.1 WuXi AppTec Corporate Summary
7.22.2 WuXi AppTec Business Overview
7.22.3 WuXi AppTec Phase I - IV Clinical Development Services Major Product Offerings
7.22.4 WuXi AppTec Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.22.5 WuXi AppTec Key News
7.23 Elixir Clinical Research
7.23.1 Elixir Clinical Research Corporate Summary
7.23.2 Elixir Clinical Research Business Overview
7.23.3 Elixir Clinical Research Phase I - IV Clinical Development Services Major Product Offerings
7.23.4 Elixir Clinical Research Phase I - IV Clinical Development Services Revenue in Global Market (2017-2022)
7.23.5 Elixir Clinical Research Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Phase I - IV Clinical Development Services Market Opportunities & Trends in Global Market
Table 2. Phase I - IV Clinical Development Services Market Drivers in Global Market
Table 3. Phase I - IV Clinical Development Services Market Restraints in Global Market
Table 4. Key Players of Phase I - IV Clinical Development Services in Global Market
Table 5. Top Phase I - IV Clinical Development Services Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Phase I - IV Clinical Development Services Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Phase I - IV Clinical Development Services Revenue Share by Companies, 2017-2022
Table 8. Global Companies Phase I - IV Clinical Development Services Product Type
Table 9. List of Global Tier 1 Phase I - IV Clinical Development Services Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Phase I - IV Clinical Development Services Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Phase I - IV Clinical Development Services Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Phase I - IV Clinical Development Services Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Phase I - IV Clinical Development Services Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Phase I - IV Clinical Development Services Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Phase I - IV Clinical Development Services Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Phase I - IV Clinical Development Services Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2023-2028
Table 30. Syneos Health Corporate Summary
Table 31. Syneos Health Phase I - IV Clinical Development Services Product Offerings
Table 32. Syneos Health Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 33. PPD Corporate Summary
Table 34. PPD Phase I - IV Clinical Development Services Product Offerings
Table 35. PPD Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 36. GVI CDS Corporate Summary
Table 37. GVI CDS Phase I - IV Clinical Development Services Product Offerings
Table 38. GVI CDS Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 39. Parexel Corporate Summary
Table 40. Parexel Phase I - IV Clinical Development Services Product Offerings
Table 41. Parexel Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 42. Clinical Leader Corporate Summary
Table 43. Clinical Leader Phase I - IV Clinical Development Services Product Offerings
Table 44. Clinical Leader Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 45. Thermo Fisher Scientific Corporate Summary
Table 46. Thermo Fisher Scientific Phase I - IV Clinical Development Services Product Offerings
Table 47. Thermo Fisher Scientific Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 48. LabCorp Corporate Summary
Table 49. LabCorp Phase I - IV Clinical Development Services Product Offerings
Table 50. LabCorp Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 51. Worldwide Clinical Trial Corporate Summary
Table 52. Worldwide Clinical Trial Phase I - IV Clinical Development Services Product Offerings
Table 53. Worldwide Clinical Trial Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 54. CROS NT Corporate Summary
Table 55. CROS NT Phase I - IV Clinical Development Services Product Offerings
Table 56. CROS NT Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 57. Dynakin Corporate Summary
Table 58. Dynakin Phase I - IV Clinical Development Services Product Offerings
Table 59. Dynakin Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 60. Rho, Inc. Corporate Summary
Table 61. Rho, Inc. Phase I - IV Clinical Development Services Product Offerings
Table 62. Rho, Inc. Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 63. Synteract Corporate Summary
Table 64. Synteract Phase I - IV Clinical Development Services Product Offerings
Table 65. Synteract Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 66. ICBio CRO Corporate Summary
Table 67. ICBio CRO Phase I - IV Clinical Development Services Product Offerings
Table 68. ICBio CRO Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 69. Sofpromed Corporate Summary
Table 70. Sofpromed Phase I - IV Clinical Development Services Product Offerings
Table 71. Sofpromed Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 72. Profil Corporate Summary
Table 73. Profil Phase I - IV Clinical Development Services Product Offerings
Table 74. Profil Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 75. ICON Plc Corporate Summary
Table 76. ICON Plc Phase I - IV Clinical Development Services Product Offerings
Table 77. ICON Plc Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 78. Clinipace Corporate Summary
Table 79. Clinipace Phase I - IV Clinical Development Services Product Offerings
Table 80. Clinipace Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 81. OCT Clinical Corporate Summary
Table 82. OCT Clinical Phase I - IV Clinical Development Services Product Offerings
Table 83. OCT Clinical Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 84. EPS Group Corporate Summary
Table 85. EPS Group Phase I - IV Clinical Development Services Product Offerings
Table 86. EPS Group Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 87. Beijing Sun-novo Pharmaceutical Research Corporate Summary
Table 88. Beijing Sun-novo Pharmaceutical Research Phase I - IV Clinical Development Services Product Offerings
Table 89. Beijing Sun-novo Pharmaceutical Research Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 90. Dmedglobal Corporate Summary
Table 91. Dmedglobal Phase I - IV Clinical Development Services Product Offerings
Table 92. Dmedglobal Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 93. WuXi AppTec Corporate Summary
Table 94. WuXi AppTec Phase I - IV Clinical Development Services Product Offerings
Table 95. WuXi AppTec Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
Table 96. Elixir Clinical Research Corporate Summary
Table 97. Elixir Clinical Research Phase I - IV Clinical Development Services Product Offerings
Table 98. Elixir Clinical Research Phase I - IV Clinical Development Services Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Phase I - IV Clinical Development Services Segment by Type in 2021
Figure 2. Phase I - IV Clinical Development Services Segment by Application in 2021
Figure 3. Global Phase I - IV Clinical Development Services Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Phase I - IV Clinical Development Services Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Phase I - IV Clinical Development Services Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Phase I - IV Clinical Development Services Revenue in 2021
Figure 8. By Type - Global Phase I - IV Clinical Development Services Revenue Market Share, 2017-2028
Figure 9. By Application - Global Phase I - IV Clinical Development Services Revenue Market Share, 2017-2028
Figure 10. By Region - Global Phase I - IV Clinical Development Services Revenue Market Share, 2017-2028
Figure 11. By Country - North America Phase I - IV Clinical Development Services Revenue Market Share, 2017-2028
Figure 12. US Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Phase I - IV Clinical Development Services Revenue Market Share, 2017-2028
Figure 16. Germany Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 17. France Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Phase I - IV Clinical Development Services Revenue Market Share, 2017-2028
Figure 24. China Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 28. India Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Phase I - IV Clinical Development Services Revenue Market Share, 2017-2028
Figure 30. Brazil Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Phase I - IV Clinical Development Services Revenue Market Share, 2017-2028
Figure 33. Turkey Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Phase I - IV Clinical Development Services Revenue, (US$, Mn), 2017-2028
Figure 37. Syneos Health Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. PPD Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GVI CDS Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Parexel Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Clinical Leader Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Thermo Fisher Scientific Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. LabCorp Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Worldwide Clinical Trial Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. CROS NT Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Dynakin Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Rho, Inc. Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Synteract Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. ICBio CRO Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Sofpromed Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Profil Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. ICON Plc Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Clinipace Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. OCT Clinical Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. EPS Group Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Beijing Sun-novo Pharmaceutical Research Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Dmedglobal Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. WuXi AppTec Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Elixir Clinical Research Phase I - IV Clinical Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
